Outset Medical Inc.

NASDAQ: OM · Real-Time Price · USD
13.29
0.40 (3.10%)
At close: Aug 15, 2025, 3:59 PM
13.29
0.00%
After-hours: Aug 15, 2025, 04:20 PM EDT

Outset Medical Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
31.42M 29.75M 29.47M 28.67M 27.39M 28.17M 30.51M 30.36M 36.04M 33.47M 32.01M 27.76M 25.06M 30.55M 28.15M 26.32M 25.22M 22.92M
Cost of Revenue
19.55M 18.69M 18.72M 18.85M 17.61M 19.95M 22.8M 23.2M 28.34M 27.04M 26.73M 23.43M 21.27M 26.11M 24.83M 23.37M 24.16M 22.63M
Gross Profit
11.87M 11.07M 10.75M 9.82M 9.78M 8.21M 7.71M 7.16M 7.7M 6.43M 5.27M 4.34M 3.78M 4.44M 3.32M 2.95M 1.05M 289K
Operating Income
-16.86M -16.4M -21.86M -23.84M -30.76M -36.91M -37.35M -45.45M -43.48M -43.48M -39.82M -41M -43.72M -36.48M -40.8M -30.14M -29.91M -29.68M
Interest Income
n/a 1.98M 2.04M 2.15M 2.47M 3.1M 2.28M 2.57M 2.67M 2.65M 1.91M 805K 459K 120K 123K 99K 164K 112K
Pretax Income
-18.44M -25.67M -25.64M -27.76M -34.3M -39.78M -38.49M -46.09M -43.91M -43.78M -41.38M -40.76M -43.74M -36.78M -41.11M -30.47M -30.17M -29.99M
Net Income
-18.54M -25.78M -25.64M -27.94M -34.45M -39.94M -38.6M -46.18M -44.05M -43.97M -41.44M -40.78M -43.84M -36.89M -41.23M -30.47M -30.21M -30.02M
Selling & General & Admin
23.44M 21.95M 24.72M 25.52M 30.81M 32.49M 32.53M 36.53M 36.27M 36.12M 33.65M 32.28M 33.98M 30.09M 32.71M 23.36M 22.93M 22.39M
Research & Development
5.29M 5.51M 7.89M 8.14M 9.73M 12.63M 12.53M 16.08M 14.91M 13.79M 11.44M 13.06M 13.52M 10.83M 11.41M 9.73M 8.03M 7.57M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
28.73M 27.46M 32.61M 33.66M 40.55M 45.13M 45.06M 52.61M 51.18M 49.91M 45.1M 45.34M 47.5M 40.92M 44.12M 33.08M 30.96M 29.96M
Interest Expense
-3.48M 3.56M 5.83M 6.07M 6.01M 5.97M 3.42M 3.21M 3.1M 2.94M 2.1M 567K 481K 422K 431K 431K 431K 422K
Selling & Marketing Expenses
14.28M 13.65M 15.45M 15.42M 18.13M 21.05M 22.19M 24.72M 24.98M 24.33M 23.63M 22.28M 23.2M 20.38M 22.99M 15.73M 13.2M 13.15M
Cost & Expenses
48.28M 46.15M 51.33M 52.51M 58.15M 65.08M 67.86M 75.82M 79.52M 76.95M 71.83M 68.76M 68.78M 67.03M 68.95M 56.46M 55.12M 52.59M
Income Tax Expense
104K 115K -4K 182K 151K 162K 112K 86K 133K 192K 64K 20K 96K 115K 125K n/a 35K 39K
Shares Outstanding (Basic)
17.74M 3.46M 3.42M 3.37M 3.46M 3.39M 3.35M 3.33M 3.26M 3.25M 3.23M 3.21M 3.18M 3.15M 3.14M 3.11M 3.05M 2.85M
Shares Outstanding (Diluted)
17.74M 3.46M 3.42M 3.37M 3.46M 3.39M 3.35M 3.33M 3.26M 3.25M 3.23M 3.21M 3.19M 3.17M 3.14M 3.11M 3.05M 2.85M
EPS (Basic)
-1.04 -7.44 -0.5 -0.55 -0.66 -0.78 -0.77 -0.93 -0.9 -0.9 -0.86 -0.85 -0.92 -0.78 -0.88 -0.65 -0.66 -0.7
EPS (Diluted)
-1.04 -7.44 -0.5 -0.55 -0.66 -0.78 -0.77 -0.93 -0.9 -0.9 -0.86 -0.85 -0.92 -0.78 -0.87 -0.65 -0.66 -0.7
EBITDA
-16.86M -20.81M -18.41M -21.69M -26.82M -32.35M -33.63M -41.1M -38.99M -39.16M -37.73M -38.6M -41.66M -35.09M -39.12M -28.73M -28.43M -28.32M
EBIT
-16.86M -22.11M -19.82M -21.69M -28.29M -33.81M -35.07M -42.88M -40.81M -40.84M -39.28M -40.19M -43.26M -36.35M -40.68M -30.04M -29.74M -29.56M
Depreciation & Amortization
n/a 1.29M 1.41M 2.15M 1.47M 1.46M 1.45M 1.78M 1.82M 1.68M 1.56M 1.6M 1.6M 1.53M 1.56M 1.57M 1.56M 1.5M